QGEN vs. SHC: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at QGEN and SHC, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | QGEN | SHC |
|---|---|---|
| Company Name | Qiagen N.V. | Sotera Health Company |
| Country | Netherlands | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Market Capitalization | 9.36 billion USD | 4.47 billion USD |
| Exchange | NYSE | NasdaqGS |
| Listing Date | June 28, 1996 | November 20, 2020 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of QGEN and SHC by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | QGEN | SHC |
|---|---|---|
| 5-Day Price Return | -2.24% | -4.20% |
| 13-Week Price Return | -10.08% | 11.95% |
| 26-Week Price Return | 1.27% | 19.70% |
| 52-Week Price Return | -2.22% | -0.57% |
| Month-to-Date Return | -7.85% | -5.18% |
| Year-to-Date Return | -3.05% | 15.06% |
| 10-Day Avg. Volume | 1.55M | 2.65M |
| 3-Month Avg. Volume | 1.34M | 1.76M |
| 3-Month Volatility | 21.56% | 29.41% |
| Beta | 0.68 | 1.84 |
Profitability
Return on Equity (TTM)
QGEN
11.48%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
QGEN’s Return on Equity of 11.48% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
SHC
11.79%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
In the upper quartile for the Life Sciences Tools & Services industry, SHC’s Return on Equity of 11.79% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
QGEN
19.58%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
A Net Profit Margin of 19.58% places QGEN in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.
SHC
4.82%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
SHC’s Net Profit Margin of 4.82% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
QGEN
23.33%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
An Operating Profit Margin of 23.33% places QGEN in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
SHC
24.14%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
An Operating Profit Margin of 24.14% places SHC in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | QGEN | SHC |
|---|---|---|
| Return on Equity (TTM) | 11.48% | 11.79% |
| Return on Assets (TTM) | 6.87% | 1.76% |
| Net Profit Margin (TTM) | 19.58% | 4.82% |
| Operating Profit Margin (TTM) | 23.33% | 24.14% |
| Gross Profit Margin (TTM) | 64.10% | 55.98% |
Financial Strength
Current Ratio (MRQ)
QGEN
2.60
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
QGEN’s Current Ratio of 2.60 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
SHC
2.38
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
SHC’s Current Ratio of 2.38 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
QGEN
0.58
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
QGEN’s Debt-to-Equity Ratio of 0.58 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
SHC
4.07
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
With a Debt-to-Equity Ratio of 4.07, SHC operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
Interest Coverage Ratio (TTM)
QGEN
27.84
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
QGEN’s Interest Coverage Ratio of 27.84 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
SHC
1.69
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
In the lower quartile for the Life Sciences Tools & Services industry, SHC’s Interest Coverage Ratio of 1.69 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.
Financial Strength at a Glance
| Symbol | QGEN | SHC |
|---|---|---|
| Current Ratio (MRQ) | 2.60 | 2.38 |
| Quick Ratio (MRQ) | 2.14 | 2.09 |
| Debt-to-Equity Ratio (MRQ) | 0.58 | 4.07 |
| Interest Coverage Ratio (TTM) | 27.84 | 1.69 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
QGEN
0.00%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
QGEN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
SHC
0.00%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
SHC currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
QGEN
0.00%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
QGEN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
SHC
0.00%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
SHC has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | QGEN | SHC |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
QGEN
23.05
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
In the lower quartile for the Life Sciences Tools & Services industry, QGEN’s P/E Ratio of 23.05 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
SHC
80.68
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
At 80.68, SHC’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Life Sciences Tools & Services industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.
Price-to-Sales Ratio (TTM)
QGEN
4.51
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
QGEN’s P/S Ratio of 4.51 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
SHC
3.89
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
SHC’s P/S Ratio of 3.89 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
QGEN
2.65
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
QGEN’s P/B Ratio of 2.65 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
SHC
8.12
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
At 8.12, SHC’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.
Valuation at a Glance
| Symbol | QGEN | SHC |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 23.05 | 80.68 |
| Price-to-Sales Ratio (TTM) | 4.51 | 3.89 |
| Price-to-Book Ratio (MRQ) | 2.65 | 8.12 |
| Price-to-Free Cash Flow Ratio (TTM) | 19.77 | 46.21 |